Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.68 - $1.31 $3,244 - $6,250
-4,771 Reduced 15.0%
27,043 $23,000
Q3 2023

Nov 14, 2023

SELL
$1.14 - $1.81 $4,269 - $6,778
-3,745 Reduced 10.53%
31,814 $43,000
Q2 2023

Aug 14, 2023

SELL
$1.79 - $4.59 $6,717 - $17,226
-3,753 Reduced 9.55%
35,559 $64,000
Q1 2023

May 15, 2023

BUY
$2.84 - $3.92 $43,119 - $59,517
15,183 Added 62.92%
39,312 $153,000
Q4 2022

Feb 14, 2023

SELL
$2.48 - $5.93 $1,478 - $3,534
-596 Reduced 2.41%
24,129 $82,000
Q3 2022

Nov 14, 2022

SELL
$4.08 - $5.82 $3,251 - $4,638
-797 Reduced 3.12%
24,725 $135,000
Q2 2022

Aug 15, 2022

SELL
$4.15 - $8.37 $9,777 - $19,719
-2,356 Reduced 8.45%
25,522 $115,000
Q1 2022

May 16, 2022

SELL
$5.91 - $14.38 $11,849 - $28,831
-2,005 Reduced 6.71%
27,878 $205,000
Q4 2021

Feb 14, 2022

SELL
$5.21 - $8.61 $21,965 - $36,299
-4,216 Reduced 12.36%
29,883 $192,000
Q3 2021

Nov 15, 2021

BUY
$4.45 - $10.63 $3,390 - $8,100
762 Added 2.29%
34,099 $198,000
Q2 2021

Aug 16, 2021

BUY
$8.11 - $11.11 $9,683 - $13,265
1,194 Added 3.71%
33,337 $344,000
Q1 2021

May 14, 2021

BUY
$9.85 - $17.69 $69,412 - $124,661
7,047 Added 28.08%
32,143 $338,000
Q4 2020

Feb 16, 2021

BUY
$14.15 - $17.19 $41,841 - $50,830
2,957 Added 13.36%
25,096 $388,000
Q3 2020

Nov 16, 2020

BUY
$14.14 - $19.71 $313,045 - $436,359
22,139 New
22,139 $323,000
Q2 2020

Aug 14, 2020

SELL
$16.6 - $25.25 $176,026 - $267,751
-10,604 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$14.38 - $27.72 $63,214 - $121,857
-4,396 Reduced 29.31%
10,604 $204,000
Q4 2019

Feb 14, 2020

SELL
$9.23 - $19.67 $92,300 - $196,700
-10,000 Reduced 40.0%
15,000 $288,000
Q4 2018

Feb 14, 2019

BUY
$8.2 - $16.95 $40,221 - $83,139
4,905 Added 24.41%
25,000 $234,000
Q3 2018

Nov 14, 2018

BUY
$17.03 - $21.18 $1,617 - $2,012
95 Added 0.48%
20,095 $342,000
Q2 2018

Aug 14, 2018

BUY
$12.0 - $19.88 $240,000 - $397,600
20,000 New
20,000 $340,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $52.7M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.